AreteiaTx logo

AreteiaTx jobs and careers

Bernardsville, NJ, United States

About AreteiaTx

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication ofimproving lung function and is found in several asthma-related treatments.

Founded in 2022 by Christopher Courts and Jorge Bartolome.

Founded
2022
Employees
11 to 50
Total funding
$425M
Headquarters
Bernardsville

Leadership

The top of AreteiaTx's org chart, with how many people report into each leader.

JBPhoto of Jorge Bartolome

Jorge Bartolome

Chief Executive Officer

12 reports

CDPhoto of Calman Prussin, M.D.

Calman Prussin, M.D.

Senior Vice President, Chief Scientific Officer

3 reports

PWPhoto of Peter Wijngaard

Peter Wijngaard

Chief Development Officer

2 reports

CCPhoto of Christopher Courts, CPA

Christopher Courts, CPA

Chief Financial Officer

1 report

TDPhoto of Tom Denwood

Tom Denwood

Chief Information Officer

MKPhoto of Mark Kreston

Mark Kreston

SVP & Chief Commercial Officer

RGPhoto of Richard Fires, MBA, GPHR

Richard Fires, MBA, GPHR

Head of Human Strategy